Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0001193125-26-116247

Principal Financial Officer bought 5,000 shares at $1.42 ($7,100)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Alfieri Michael Principal Financial Officer 2026-03-18 Purchase +5,000 $1.42 $7,100 7,500 D
Open-market purchases · 5,000 sh · avg $1.42 · $7,100
Loading xslF345X06/ownership.xml…